Table 3.
Rehabilitation therapy use according to patients' characteristics in the period of 2013–2015.
| Characteristics | All types | PT | OT | ST | ||||
|---|---|---|---|---|---|---|---|---|
| AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | |
| Sex | ||||||||
| Male | Ref. | Ref. | Ref. | Ref. | ||||
| Female | 1.668 | 1.274–2.182 | 1.755 | 1.338–2.301 | 1.214 | 0.868–1.698 | 0.894 | 0.493–1.619 |
|
| ||||||||
| Age (y) | ||||||||
| 0–59 | Ref. | Ref. | Ref. | Ref. | ||||
| 60–69 | 2.806 | 1.550–5.077 | 3.139 | 1.703–5.785 | 2.483 | 1.144–5.391 | 4.13 | 0.872–19.550 |
| 70–79 | 4.053 | 2.310–7.113 | 4.576 | 2.557–8.187 | 3.413 | 1.635–7.122 | 3.566 | 0.782–16.260 |
| 80+ | 3.773 | 2.068–6.884 | 4.041 | 2.172–7.516 | 3.246 | 1.475–7.142 | 2.99 | 0.585–15.293 |
|
| ||||||||
| Income | ||||||||
| Low | Ref. | Ref. | Ref. | Ref. | ||||
| Middle | 1.095 | 0.767–1.565 | 1.125 | 0.786–1.610 | 0.965 | 0.614–1.516 | 1.033 | 0.411–2.598 |
| High | 1.442 | 1.018–2.045 | 1.412 | 0.994–2.006 | 1.219 | 0.791–1.879 | 2.066 | 0.902–4.736 |
|
| ||||||||
| Region of residence | ||||||||
| Seoul/Incheon | Ref. | Ref. | Ref. | Ref. | ||||
| Gyeonggi/Gangwon | 0.825 | 0.571–1.192 | 0.852 | 0.590–1.237 | 1.106 | 0.696–1.757 | 0.887 | 0.411–1.913 |
| Busan/Daegu/Ulsan/Gyeongsang | 0.921 | 0.639–1.327 | 0.954 | 0.661–1.377 | 1.27 | 0.807–1.999 | 0.465 | 0.189–1.145 |
| Daejeon/Sejong/Chungcheong | 0.879 | 0.535–1.445 | 0.904 | 0.548–1.489 | 1.034 | 0.546–1.957 | 1.117 | 0.404–3.090 |
| Gwangju/Jeolla/Jeju | 0.806 | 0.525–1.239 | 0.871 | 0.566–1.340 | 0.952 | 0.546–1.661 | 0.814 | 0.315–2.106 |
|
| ||||||||
| Comorbidities | ||||||||
| No | Ref. | Ref. | Ref. | Ref. | ||||
| Yes | 1.457 | 0.976–2.175 | 1.397 | 0.935–2.087 | 1.546 | 0.977–2.446 | 1.758 | 0.821–3.767 |
|
| ||||||||
| Disability grade | ||||||||
| None | Ref. | Ref. | Ref. | Ref. | ||||
| Mild to moderate (3–6) | 2 | 1.486–2.690 | 2.079 | 1.544–2.800 | 2.56 | 1.802–3.635 | 2.453 | 1.295–4.646 |
| Severe (1-2) | 2.939 | 1.815–4.758 | 2.738 | 1.692–4.430 | 1.8 | 1.000–3.239 | 3.078 | 1.214–7.802 |
|
| ||||||||
| Levodopa-equivalent dose | ||||||||
| <200 | Ref. | Ref. | Ref. | Ref. | ||||
| ≥200, <400 | 1.016 | 0.703–1.470 | 1.076 | 0.741–0.903 | 0.951 | 0.581–1.557 | 2.284 | 0.638–8.176 |
| ≥400, <600 | 1.338 | 0.882–2.030 | 1.376 | 0.903–2.096 | 1.234 | 0.715–2.129 | 3.103 | 0.828–11.625 |
| ≥600, <800 | 1.647 | 0.994–2.730 | 1.768 | 1.064–2.940 | 1.344 | 0.706–2.560 | 2.964 | 0.695–12.642 |
| ≥800 | 4.05 | 2.484–6.601 | 3.952 | 2.423–6.446 | 3.792 | 2.174–6.616 | 9.438 | 2.601–34.253 |
PT, physical therapy; OT, occupational therapy; ST, swallowing therapy.